Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Cash from Investing Activities (2023 - 2026)

Contineum Therapeutics' Cash from Investing Activities history spans 4 years, with the latest figure at -$39.3 million for Q1 2026.

  • Quarterly Cash from Investing Activities fell 363.55% to -$39.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$57.9 million through Mar 2026, up 8.84% year-over-year, with the annual reading at -$3.7 million for FY2025, 94.68% up from the prior year.
  • Cash from Investing Activities came in at -$39.3 million for Q1 2026, up from -$47.5 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $14.9 million in Q3 2025 to a low of -$47.5 million in Q4 2025.
  • The 4-year median for Cash from Investing Activities is -$9.4 million (2024), against an average of -$13.7 million.
  • The largest YoY upside for Cash from Investing Activities was 149.5% in 2025 against a maximum downside of 405.46% in 2025.
  • Contineum Therapeutics' Cash from Investing Activities stood at $9.0 million in 2023, then crashed by 203.96% to -$9.4 million in 2024, then plummeted by 405.46% to -$47.5 million in 2025, then rose by 17.16% to -$39.3 million in 2026.
  • Per Business Quant, the three most recent readings for CTNM's Cash from Investing Activities are -$39.3 million (Q1 2026), -$47.5 million (Q4 2025), and $14.9 million (Q3 2025).